Menu
- Home
+ - Publications
+
- Archives
+
- BCIQ
+
- Conferences
+
- eLearning
+
- Follow Us
Latest News
8:00 AM Oct 22, 2018
Achaogen furnishes data for Pew antibiotic platform targeting Gram-negative bacteria
Achaogen Inc. (NASDAQ:AKAO) gave data from a discontinued program to The Pew Charitable Trusts' Shared...
7:48 AM Oct 22, 2018
Zai gains Hong Kong approval of PARP inhibitor Zejula
Zai Lab Ltd. (NASDAQ:ZLAB) is preparing for its first-ever product launch after Hong Kong's Department of...
5:02 AM Oct 22, 2018
Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal
With $33 million in new series A funding, a portfolio of preclinical assets from The Medicines Co. (NASDAQ:...
6:10 PM Oct 21, 2018
No responses in monotherapy arm for Merck STING agonist; Aduro shares off
Merck & Co. Inc. (NYSE:MRK) said MK-1454 as monotherapy led to no responses in 20 evaluable patients...
4:38 PM Oct 19, 2018
CHMP backs Takhzyro, Dengue vaccine, biosimilar Herceptin
EMA’s CHMP recommended several approvals Friday, including hereditary angioedema (HAE) mAb Takhzyro...
4:32 PM Oct 19, 2018
FDA, EMA delay review of Opdivo/Yervoy for first-line NSCLC
Bristol-Myers Squibb Co. (NYSE:BMY) said Friday that FDA and EMA have both pushed back their reviews of...
3:47 PM Oct 19, 2018
Clovis' Rubraca leads to 44% ORR in Phase II for CRPC
Clovis Oncology Inc. (NASDAQ:CLVS) said twice-daily Rubraca rucaparib led to a confirmed objective...
3:42 PM Oct 19, 2018
FDA approves Dupixent for asthma
FDA approved Dupixent dupilumab from Sanofi (Euronext:SAN; NYSE:SNY) and Regeneron Pharmaceuticals Inc. (...
3:35 PM Oct 19, 2018
Management tracks: AbbVie, Adverum
AbbVie Inc. (NYSE:ABBV) said EVP and CFO William Chase will retire in mid-2019. Effective immediately,...
3:27 PM Oct 19, 2018
FDA asks peers to globalize generic drug development
FDA is calling on international regulatory authorities to develop harmonized guidelines on scientific and...
12:25 PM Oct 19, 2018
LogicBio marks week’s third IPO to miss price target
LogicBio Therapeutics Inc. (NASDAQ:LOGC) priced its IPO below its proposed range late Thursday, joining...
9:52 AM Oct 19, 2018
Study uncovers large batch effects in TCGA exome sequencing data
A preprint article published in bioRxiv identified large cross-institutional batch effects for a subset of...
5:26 AM Oct 19, 2018
Ahead of Phase II, TP raises $80M mezzanine round
Oncology company TP Therapeutics Inc. (San Diego, Calif.) raised $80 million in a mezzanine round and...
3:37 PM Oct 18, 2018
CMS’s Verma outlines new drug payment options
CMS Administrator Seema Verma Thursday outlined three types of payment arrangements the agency is...
3:14 PM Oct 18, 2018
Big gain for Proteostasis on Phase I data for CF doublet
Proteostasis Therapeutics Inc. (NASDAQ:PTI) jumped $8.46 (448%) to $10.35 on Thursday after reporting that...
3:09 PM Oct 18, 2018
AbbVie, Morphic partner on antifibrotic integrins
AbbVie Inc. (NYSE:ABBV) agreed to pay Morphic Therapeutic (Waltham, Mass.) $100 million up front for...
3:07 PM Oct 18, 2018
UC Berkeley group identifies new Cas enzyme
In a Science paper published Thursday, Jennifer Doudna's lab reported a new family of CRISPR-associated...
1:10 PM Oct 18, 2018
WideTrial seeks to increase expanded access programs by helping companies recover costs
FDA has authorized WideTrial Inc. (San Francisco, Calif.) to charge payment for an expanded access program...
12:57 PM Oct 18, 2018
Management tracks: Autolus, Bayer, Cambridge Allergy
T cell cancer therapy company Autolus Therapeutics plc (NASDAQ:AUTL) hired Adam Hacker as SVP for...
11:48 AM Oct 18, 2018
Apellis pauses Phase III trials after single lot of APL-2 causes inflammation
Apellis Pharmaceuticals Inc. (NASDAQ:APLS) lost $2.85 (17%) to $13.86 on Thursday after it voluntarily...
About Biocentury
Contact
Support
Products & Solutions
Legal
- Follow Us
What is BioCentury?
BioCentury employs a fully integrated multimedia platform — including publications, video, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.